"The brain as a target of inflammatory processes" (CS and WB) and the Gemeinn€ utzige Hertie Foundation (to CS).
In addition to therapeutically addressing the plethora of inflammatory mediators present, remyelination of axons is considered as one of the most important endogenous axon-protective mechanisms. Aside from restoring the conductive properties of the axon, remyelination provides insulation of the axon against a potentially hostile microenvironment and restores the close metabolic interaction with oligodendrocytes (F€ unfschilling et al., 2012; Lee et al., 2012; Morrison et al., 2015) . The correlation of early remyelination and axonal damage and whether damaged axons can be remyelinated, is unknown so far.
To study the interrelation between demyelination, remyelination, and axonal damage in detail, we employed the mouse model of cuprizone-induced demyelination and focal lysolecithin-induced demyelination and performed tight time course experiments assessing the evolution of remyelination and acute axonal damage. We found that the density of APP-positive axons gradually declined after removing cuprizone from the diet and during the phase of lesion repair after lysolecithin injection, indicating an overall beneficial role of remyelination.
In addition, APP-positive axonal profiles enwrapped by myelin sheaths were found in early remyelinating multiple sclerosis lesions as well as during remyelination in our experimental models. In the present work, we took also advantage of a cohort of patients with early and late stage remyelinated lesions and assessed the density of damaged and preserved axons. No significant difference in the density of preserved and damaged axons could be observed between remyelinating and demyelinating multiple sclerosis lesions early in lesion formation. However, we could demonstrate that in late stage disease, the amount of preserved axons was significantly higher in remyelinated than in demyelinated multiple sclerosis lesions.
Our findings suggest that the re-establishment of a myelin sheath does not depend on a functional axonal transport and intact axonal metabolism and might even aid the recuperation of damaged axons.
Thus, our data support a protective role of remyelination in early as well as late stage lesion development.
| MATERIALS A ND METHODS

| Multiple sclerosis tissue
In this study formalin-fixed and paraffin-embedded biopsy and autopsy CNS tissue of patients with multiple sclerosis was used, which was collected at the Institute of Neuropathology at the University Medical Centre G€ ottingen (Supplementary Table 1 and 2). Lesions were assessed by A.J. and C.S. according to criteria described elsewhere (Br€ uck et al., 1994 (Br€ uck et al., , 1995 Kutzelnigg et al., 2005; Lassmann, 2011; Lucchinetti et al., 2000; Schuh et al., 2014) . The study was performed in accordance with national and local ethics regulations and approved by the UMG ethics committee.
| Animals
For all in vivo experiments 6 to 7-week-old male C57BL/6J mice and adult female Lewis rats (200-220 g) were purchased from Charles River (Sulzfeld, Germany). Up to 6 animals were housed together on a 12/12 h light/dark cycle and had access to food and water ad libitum.
Animal experiments were conducted in accordance with the European Communities Council Directive of November 24 th , 1986 (86/EEC) and were approved by the Government of Lower Saxony, Germany.
| Cuprizone mouse model
About 7 to 8-week-old male C57BL/6J mice were fed for 6 weeks with the cupper chelator cuprizone (0.25% in normal chow) to induce demyelination in the brain. After cuprizone withdrawal mice were fed with normal diet to analyze remyelination. During de-and remyelination, that is after 6 weeks of cuprizone treatment and 2, 3, 4, 5, 6, 7, 14 and 21 days after cuprizone diet cessation, brains of mice were harvested and processed for analysis by histochemistry and immunohistochemistry. Untreated, age-matched mice were used as a control.
Mouse brain tissue was fixed with 4% paraformaldehyde (PFA) and embedded into paraffin. For histological evaluation 1 mm coronal sections were used.
| Focal lysolecithin-induced demyelination
Adult Lewis rats (200-220 g) were anaesthetized by intraperitoneal injection of ketamine/xylazine. The scalp was opened and the animal was mounted on a stereotactic device. A small hole (Ø 2 mm) was drilled 2 mm lateral and 1 mm caudal to the bregma. One ml of 0.5% lysolecithin (Sigma-Aldrich) diluted in sterile PBS was slowly (3 min) injected into the corpus callosum (2.5 mm depth) using a fine calibrated glass capillary. Afterwards the capillary was removed and the skin was sutured. Animals were perfused 3, 6, 12, and 20 days postinjection for histochemical and immunohistochemical analysis.
| Histology
Bielschowsky silver impregnation and Luxol fast blue periodic acid Schiff (LFB-PAS) staining were performed according to standard procedures. Primary antibodies utilized for immunohistochemistry were against injured axons (APP, 1:2,000, clone 22C11, Chemicon) and nonphosphorylated neurofilaments (SMI32, 1:1,000, Covance, Princeton, NJ, USA), healthy phosphorylated neurofilaments/axons (SMI31, 1:10,000, Covance, Princeton, NJ, USA), myelin basic protein (MBP, 1:2,000, Dako), activated microglia (Mac3, also known as Lamp2, 
| Morphometry and data acquisition
The level of demyelination of the corpus callosum after cuprizone treatment was assessed in LFB-PAS stained and MBP immunostained
sections by a semi-quantitative score: no demyelination (0), 0-33% demyelination (1), 33%-66% demyelination (2), and more than 66% demyelination (3) (Hiremath et al., 1998 Axonal density within the lesions was determined in sections stained with SMI31 and Bielschowsky silver impregnation by using an axonal counting grid with 25 cross-points at a magnification of 10003 under oil immersion. The number of axons that crossed a grid line was counted as a fraction of the total number of cross-points. The number of axons crossing the points in normal appearing white matter was set to 100%. The degree of axon reduction in the lesion is given as the percentage of axon density compared with normal appearing white matter.
| Imaging
All images were acquired using either the Fluorescence microscope BX51 (Olympus) and Camera DP71/XM10 (Olympus) or the Laser scanning confocal microscope FluoView FV1000 (Olympus). They are presented as captured; only white balance was applied to light microscopical images. To assess whether the axons experienced damage because of demyelination, the activation of microglia or the reactivation of astrocytes, we determined the microgliosis and astrogliosis by   FIG URE 1 Design of the cuprizone experiments to investigate the timing and relation of acute axonal damage and remyelination. 7 to 8-week-old male C57BL/6J mice were fed for 6 weeks with a 0.25% cuprizone diet to induce demyelination in the corpus callosum. Demyelinated lesions remyelinate after cuprizone withdrawal. To study early and late remyelination, CNS tissue was harvested from days 2 to 7, and on days 14 and 21 after cuprizone diet cessation
| Statistical analysis
Comprehensive assessment of white matter pathology early and late after cuprizone-induced demyelination. (a) Representative images of the medial corpus callosum of control mice and mice after cuprizone challenge for 6 weeks and after 4 days of recovery. Myelin assessment by LFB-PAS histochemistry and MBP immunohistochemistry (IHC) indicated an almost complete demyelination of the corpus callosum after 6 weeks of cuprizone feeding. Significant remyelination was observed 4 days after diet cessation. Acute axonal damage (APP 1 axons) decreased during remyelination in the cuprizone model. Microglial cells were activated during demyelination. The number of 3.2 | Axons with disturbed axonal transport were remyelinated after cuprizone withdrawal and after lysolecithin-induced demyelination
Nikic and colleagues reported that axonal damage is reversible and does not lead to axonal degeneration in all cases (Nikic et al., 2011) .
To determine whether injured axons can be remyelinated, which would point to a recuperative role of the newly established myelin sheath, a comprehensive confocal microscopy investigation was per- 
| DISCUSSION
The precise timing of early remyelination in relation to axonal damage
has not yet been studied in detail. In the present study, we performed tight time course experiments in the cuprizone mouse model and in focal lysolecithin-induced demyelination. We observed that damaged axons are able to gain a new myelin sheath, which may act as a "patch"
and may thereby promote axonal recuperation. It has long been assumed that remyelination is beneficial for axonal preservation in multiple sclerosis in the long term (Kornek et al., 2000; Kuhlmann, Lingfeld, Bitsch, Schuchardt, & Br€ uck, 2002; Patrikios et al., 2006) , which we confirmed in our study of early and late stage multiple sclerosis lesions.
Hence, our data support the notion that therapies promoting remyelination would be beneficial at early and late stages of lesion development to increase the axonal preservation.
After cuprizone challenge the corpus callosum of mice exhibited acutely damaged axons, which were identified as APP 1 axons or axonal spheroids. APP 1 axonal profiles may reflect axonal transection or reversible transport disturbance (Nikic et al., 2011) . The temporal sequence of axonal swelling and transection as a consequence of axonal damage and the reversibility of acute axonal damage were recently studied in EAE by in vivo imaging. This work also showed that APP 1 axons in the immediate perilesional area of early lesions were in part myelinated, suggesting that acute axonal damage may in part occur & Matsushima, 2008; Matsushima & Morell, 2001; Mildner et al., 2007) . Therefore, the mechanisms of axonal pathology and recuperation might differ as well. However, we also observed remyelination of damaged axons in lysolecithin-induced focal demyelination, indicating that remyelination of functionally impaired axons is not restricted to cuprizone-induced demyelination.
In the present study, the number of injured axons decreased continuously during remyelination in the cuprizone model and also in lysolecithin-induced demyelination. Remyelination thus seemed to be axon-protective, and no evidence for heightened vulnerability of axons during early remyelination was observed in our models (Irvine & Blakemore, 2006 For most of the studies exploring mechanisms of demyelination, remyelination and axonal damage in the cuprizone mouse model, time intervals of weeks or months were used (Gudi et al., 2009; Lindner, Fokuhl, Linsmeier, Trebst, & Stangel, 2009; Lindner et al., 2008; Skripuletz et al., 2013; Stidworthy, Genoud, Suter, Mantei, & Franklin, 2003) .
In the present study the very short time intervals of only days enabled a detailed analysis of early remyelination and axonal damage. Acute axonal damage decreased continuously during recovery presumably in Tomonaga, & Ikeda, 1991) and were observed up to four weeks after the insult (Bramlett, Kraydieh, Green, & Dietrich, 1997; Pierce, Trojanowski, Graham, Smith, & McIntosh, 1996) . Therefore, the majority of the axonal damage probably occurred during cuprizone treatment and demyelination and was still detectable during the phase of remyelination.
Our study revealed that 25% of APP 1 axons appeared myelinated already after 7 days of remyelination in the cuprizone model. The temporal relation of axonal damage and early remyelination suggests that axons were efficiently remyelinated independent of their functional impairment. We could also identify APP 1 myelinated axons in lysolecithin-induced demyelination in the stage of lesion repair. These data are in line with work on chronically demyelinated axons, which can still be efficiently remyelinated (Foote & Blakemore, 2005; Mason et al., 2004) . Thus, it was proposed that efficient remyelination depends rather on the presence of myelinating oligodendrocytes and specific environmental factors than on the axons themselves. Moreover, a functional axonal transport does not seem to be a necessary precondition for the establishment of a proper myelin sheath.
We could demonstrate that the number of myelinated injured axons was increased in early remyelinating multiple sclerosis lesions compared with demyelinating lesions. This observation suggests that a similar sequence of events might lead to myelinated damaged axons in multiple sclerosis. However, the models employed here are devoid of a significant contribution of adaptive immune cells, and primarily suited to investigate mechanisms of de-and remyelination. Yet, in multiple sclerosis, the focal and diffuse immune activation, including adaptive and innate immune cells, might influence the process of remyelination and the extent and occurrence of axonal damage.
In conclusion, our work contributes to the elucidation of the mechanisms that are important for axonal preservation and remyelination.
The findings of this study demonstrate that axons with functional impairment, including axonal transport disturbances can still be remyelinated. Remyelination may not only restore saltatory conduction, but may also actively assist in the preservation of axonal integrity after axonal damage.
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